TREM2 and amyloidosis: The current findings are also broadly consistent with a previous brain autopsy study reporting that individuals carrying TREM2 mutations exhibit lower amyloid plaque‐associated microglia activation, less microglial clustering (Parhizkar et al, 2019), and higher neuritic plaque score (Prokop et al, 2019).